Trademark Overview
          
          On Tuesday, July 8, 2025, a trademark application was filed for PARMOL with the United States Patent and Trademark Office. The USPTO has given the PARMOL trademark a serial number of 99273677. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, October 27, 2025. This trademark is owned by Newcastle Bioscience, LLC. The PARMOL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations used to treat one or more of the following: infectious diseases, cancer, pain, inflammation, cardiovascular diseases, neurological diseases, psychiatric conditions, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, ophthalmologic diseases, reproductive diseases, and respiratory conditions